The impact of daily cotrimoxazole prophylaxis and antiretroviral therapy on mortality and hospital admissions in HIV-infected Zambian children.

Samankaltaisia teoksia

• Adherence to both cotrimoxazole and placebo is associated with improved survival among HIV-infected Zambian children.
  Tekijä: Walker, A, et al.
  Julkaistu: (2009)
• Improved growth and anemia in HIV-infected African children taking cotrimoxazole prophylaxis.
  Tekijä: Prendergast, A, et al.
  Julkaistu: (2011)
• Effect of cotrimoxazole on causes of death, hospital admissions and antibiotic use in HIV-infected children.
  Tekijä: Mulenga, V, et al.
  Julkaistu: (2007)
• Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP Trial.
  Tekijä: Walker, A, et al.
  Julkaistu: (2006)
• The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia.
  Tekijä: Ryan, M, et al.
  Julkaistu: (2008)